Brief: Jubilant Pharmova Says FDA Issued 8 Observations After Inspection Of Nanjangud Facility
Dec 14 (Reuters) - Jubilant Pharmova Ltd JUBA.NS :
* USFDA COMPLETES INSPECTION OF ITS API MANUFACTURING
FACILITY AT
NANJANGUD, INDIA
* US FDA HAS ISSUED EIGHT OBSERVATIONS PURSUANT TO
COMPLETION OF
INSPECTION
* COMPANY WILL SUBMIT AN ACTION PLAN ON OBSERVATIONS AND
WILL
ENGAGE WITH US FDA FOR NEXT STEPS
Source text for Eikon: ID:nBSE8NyYKW
Further company coverage: JUBA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures